Children's Hospital Los Angeles, University of Southern California, Keck School of Medicine, 4650 Sunset Blvd., Los Angeles, CA 90027, USA.
Wayne State University, Children's Hospital of Michigan, Detroit, MI 48201, USA.
Thromb Res. 2018 Mar;163:146-152. doi: 10.1016/j.thromres.2018.01.043. Epub 2018 Feb 2.
Medication errors frequently occur during transition from the inpatient to outpatient setting. Anticoagulants are associated with serious medical errors, including major bleeding. Standardized transition of care (TOC) techniques in patients with venous thromboembolism (VTE) have not been developed.
This ongoing project conducted by the American Thrombosis and Hemostasis Network (ATHN) aims to improve TOC for newly diagnosed VTE patients on anticoagulation from the inpatient to outpatient setting, and identify characteristics of patients on direct oral anticoagulants (DOACs) and their TOC. There are two main phases, a Pre-Intervention and a Quality Intervention Phase. For both phases data are collected regarding patient demographics, VTE characteristics, and patients' knowledge and feedback regarding their VTE and anticoagulant discharge instructions. In addition, for the Quality Intervention Phase, a standardized comprehensive discharge instruction module specific for each anticoagulant is administered followed by a one-week phone call.
Sixteen ATHN-affiliated sites are participating. There are 218 patients enrolled in the Pre-Intervention Phase. The majority are adults (58.5%), women (52.4%) and non-Hispanic ethnicity (82.2%). The main risk factors for VTE were length of hospital stay of more than seven days and obesity in the pediatric and adult population respectively. Enoxaparin and DOACs were predominantly prescribed for the pediatric and adult population respectively.
This TOC quality intervention initiative for newly diagnosed patients with VTE aims to demonstrate that implementation of a standardized TOC model is feasible and can improve patient knowledge, satisfaction, compliance, reduce anticoagulant complications and hospital readmissions in both the pediatric and adult populations.
从住院患者过渡到门诊患者时,经常会发生用药错误。抗凝剂与严重的医疗错误有关,包括大出血。尚未制定静脉血栓栓塞症(VTE)患者的标准化过渡护理(TOC)技术。
美国血栓与止血网络(ATHN)正在进行的这项项目旨在改善新诊断为 VTE 患者的抗凝治疗从住院患者到门诊患者的 TOC,并确定直接口服抗凝剂(DOAC)患者的特征及其 TOC。有两个主要阶段,即预干预阶段和质量干预阶段。在这两个阶段,都收集了有关患者人口统计学,VTE 特征以及患者对 VTE 和抗凝剂出院说明的知识和反馈的信息。此外,在质量干预阶段,对每个抗凝剂实施了标准化的综合出院说明模块,然后进行了为期一周的电话随访。
有 16 个 ATHN 附属站点参与了该项目。有 218 名患者入组了预干预阶段。大多数患者为成年人(58.5%),女性(52.4%)和非西班牙裔(82.2%)。VTE 的主要危险因素分别是住院时间超过七天和儿科和成年人群中的肥胖。依诺肝素和 DOAC 分别主要用于儿科和成年人群。
这项针对新诊断的 VTE 患者的 TOC 质量干预计划旨在证明实施标准化的 TOC 模型是可行的,可以改善患者的知识,满意度,依从性,减少抗凝并发症和儿科和成年人群的住院再入院率。